Synergistic effects of co‐expression of the Th1 cytokines il‐2 and IFNγ on generation of murine tumor‐reactive cytotoxic cells
暂无分享,去创建一个
A. McAdam | S. Harkins | J. Frelinger | E. Lord | E. Hutter | B. Pulaski
[1] J. Frelinger,et al. Transfection of Transforming Growth Factor-β Producing Tumor EMT6 with Interleukin‐2 Elicits Tumor Rejection and Tumor Reactive Cytotoxic T‐Lymphocytes , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[2] M. Colombo,et al. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? , 1994, Immunology today.
[3] P. Musiani,et al. Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene , 1993 .
[4] A. McAdam,et al. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. , 1993, Cancer research.
[5] E. Jaffee,et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. Venzon,et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. , 1993, The Journal of clinical investigation.
[7] J. Yewdell,et al. Identification of human cancers deficient in antigen processing , 1993, The Journal of experimental medicine.
[8] P. Leder,et al. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. , 1992, Science.
[9] M. Schilham,et al. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4 , 1991, Nature.
[10] P. Frost,et al. Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression. , 1991, Cancer research.
[11] J. Frelinger,et al. Alteration of the metastatic potential of line 1 lung carcinoma cells: opposite effects of class I antigen induction by interferons versus DMSO or gene transfection. , 1990, Cellular immunology.
[12] S. Miyatake,et al. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[13] E. Maraskovsky,et al. IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. , 1989, Journal of immunology.
[14] L. Harwell,et al. Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Bahler,et al. Enhanced immune recognition of H-2 antigen-deficient murine lung carcinoma cells following treatment with dimethyl sulfoxide. , 1985, Cancer research.
[16] R. Kiessling,et al. „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype , 1975, European journal of immunology.
[17] R. Coffman,et al. Regulation of immunity to parasites by T cells and T cell-derived cytokines. , 1992, Annual review of immunology.
[18] T. Mosmann. Cytokine secretion patterns and cross-regulation of T cell subsets , 1991, Immunologic research.
[19] K. Cerosaletti,et al. Class‐I MHC expression in the mouse lung carcinoma, line 1: A model for class‐I inducible tumors , 1991, International journal of cancer. Supplement = Journal international du cancer. Supplement.